Skip to main content
Quest Diagnostics Home

Severe Topical Corticosteroid Withdrawal Syndrome or Enigmatic Drug Eruption?

Severe topical corticosteroid withdrawal syndrome or enigmatic drug eruption?

Authors: Tracy A, Durrani S, Mir A.

J Allergy Clin Immunol Pract. 2022 Apr;10(4):1125-1126. doi: 10.1016/j.jaip.2022.01.034.

Specialties: Dermatology

Disclaimer: One or more of the authors of this publication were employed at the time by BluePrint Genetics, a subsidiary of Quest Diagnostics.

Our company

Locations Careers Investors Specialty labs Newsroom
Site map   •   Privacy   •   Terms   •   Cookie notice   •   Contact us   •   Language assistance / non-discrimination   •   Asistencia de idiomas / Aviso de no discriminación   •   語言協助 / 不歧視通知   •   Privacy Shield   •   DO NOT SELL MY PERSONAL INFORMATION   •   Accessibility

Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2022 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.